BioRem Inc. (TSXV:BRM)
Canada flag Canada · Delayed Price · Currency is CAD
2.530
+0.020 (0.80%)
Mar 20, 2026, 9:30 AM EST

BioRem Income Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
34.7337.4225.1728.8624.4824.38
Revenue Growth (YoY)
-13.85%48.69%-12.81%17.91%0.42%18.05%
Cost of Revenue
26.3127.3618.1420.118.2417.36
Gross Profit
8.4210.067.028.766.247.02
Selling, General & Admin
5.325.623.915.793.914.77
Research & Development
0.090.040.030.10.010.03
Other Operating Expenses
-0.030.050.020.240.24-0.5
Total Operating Expenses
5.375.713.966.124.174.3
Operating Income
5.938.495.855.024.15.39
Interest Expense
-0.17-0.2-0.27-0.26-0.04-0.04
Total Non-Operating Income (Expense)
-0.17-0.2-0.27-0.26-0.04-0.04
Pretax Income
5.768.35.584.774.075.35
Provision for Income Taxes
0.771.10.610.770.740.59
Net Income
2.113.042.181.611.32.09
Net Income to Common
2.113.042.181.611.32.09
Net Income Growth
-59.44%39.66%35.11%24.34%-37.89%-
Shares Outstanding (Basic)
161616153639
Shares Outstanding (Diluted)
191917183740
Shares Change (YoY)
4.60%9.40%-2.55%-53.08%-5.32%2.20%
EPS (Basic)
0.130.190.140.100.040.05
EPS (Diluted)
0.110.160.130.090.040.05
EPS Growth
-62.29%23.08%44.44%125.00%-20.00%-
Free Cash Flow
2.233.31-0.061.243.713
Free Cash Flow Growth
-32.82%---66.50%23.48%25.45%
Free Cash Flow Per Share
0.120.18-0.000.070.100.08
Gross Margin
24.25%26.87%27.90%30.36%25.48%28.79%
Operating Margin
17.06%22.70%23.25%17.41%16.77%22.13%
Profit Margin
6.08%8.13%8.66%5.59%5.30%8.57%
FCF Margin
6.41%8.85%-0.25%4.30%15.14%12.31%
EBITDA
6.448.976.235.374.455.75
EBITDA Margin
18.55%23.96%24.77%18.62%18.17%23.58%
EBIT
5.938.495.855.024.15.39
EBIT Margin
17.06%22.70%23.25%17.41%16.77%22.13%
Effective Tax Rate
13.34%13.32%10.93%16.16%18.11%10.96%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.